Clene Inc.Clene Inc.Clene Inc.

Clene Inc.

No trades
See on Supercharts
Market capitalization
‪55.86 M‬USD
−0.5450USD
‪−49.50 M‬USD
‪654.00 K‬USD
‪73.54 M‬
Beta (1Y)
−1.53

About Clene Inc.

CEO
Robert Dee Etherington
Headquarters
Salt Lake City
Website
Employees (FY)
85
Founded
2013
FIGI
BBG00YQ7WGM6
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.